Healthcare
Exchange
Working Group
Project
Pharma & Bioprinting
Focusing on next-generation medical manufacturing, this group drives innovation in 3D-printed drugs, tissue models, and customized implants. It seeks to accelerate biotech applications and bridge lab-to-clinic workflows.
This working group brings together experts from across the pharmaceutical and biotech sectors to explore how additive manufacturing and bioprinting can advance drug delivery and pre‑clinical research.
We focus on developing innovative dosage forms, bioprinted tissue models, and practical AM solutions that enhance pharmaceutical processes. The group offers a collaborative space to share ideas, showcase applications, and jointly drive new technologies into real‑world practice.

Dominic Duda
Lead Technology Solutions
Takeda Pharmaceutical AG
- 16Jan
- 12Dec
Pharmaceutics Working Group Meeting
Let's finalize our white paper!
- 25Jun
MGA Medical | Consultation on 3D Printing in Pharmaceutics: Best practices and technologies (open to everyone)
Together with leading pharma and tech partners including Takeda, IOI Oleo GmbH, Replique, ARBURG Additive Manufacturing, BioMed Center Innovation gGmbH and more, we’ll discuss the global landscape, best practices and technologies.
- 13Mar–15Mar
MGA Medical | Working Group Pharmaceutics
Focusing on the manufacturing of medications, format parts and tools in the pharma industry.







